| Bioactivity | N,N'-Bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine is a enterochelin hydrolyzed product. N,N'-Bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine can inhibit the invasion of murine colon cancer cells 26-L5 with an IC50 of 2.7 μM, and has anti-tumor effect. In addition, N,N'-Bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine has no appreciable antimicrobial activities against Micrococcus luteus, Escherichia coli and Candida albicans[1][2]. |
| CAS | 30414-15-4 |
| Formula | C20H20N2O11 |
| Molar Mass | 464.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Igarashi Y, et al. Catechoserine, a new catecholate-type inhibitor of tumor cell invasion from Streptomyces sp. J Antibiot (Tokyo). 2012 Apr;65(4):207-9. [2]. O'Brien IG, et al. Enterochelin hydrolysis and iron metabolism in Escherichia coli. Biochim Biophys Acta. 1971 Jun 22;237(3):537-49. |
N,N'-Bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine
CAS: 30414-15-4 F: C20H20N2O11 W: 464.38
N,N'-Bis(2,3-Dihydroxybenzoyl)-O-L-seryl-L-serine is a enterochelin hydrolyzed product. N,N'-Bis(2,3-Dihydroxybenzoyl)-O
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.